Teleradiologia de Colombia, a leading diagnostic imaging services provider in Latin America, is rolling out Oxipit AI solutions across its network. Oxipit AI suite will produce preliminary chest X-Ray AIreports and identify healthy patient images with no abnormalities to augment radiologist productivity and improve workflow. It marks the first Oxipit deployment in Colombia with more announcements in Latin America expected soon.

Teleradiología de Colombia is the largest teleradiology services provider in Colombia, with leading healthcare groups in its client portfolio. The company is part of ATRYS medical group. ATRYS radiology units report on more than one million imaging cases per year and employ more than 100 radiology specialists.

“Innovations are at the core of Teleradiologia de Colombia’s mission to deliver precision medicine to the patients,” says Director of Innovation at Teleradiologia de Colombia Dr. José Hernando Morales. We strive to provide top medical specialists with cutting edge technological tools to improve their work routine.”

Prior to the rollout, Oxipit AI solutions underwent thorough testing and received very positive feedback from the company’s radiologists. Oxipit made certain tweaks to the performance of its AI suite to better fit Teleradiologia de Colombia’s special requirements.

“We highly encourage all our clients to ‘try before you buy’ and evaluate the performance of AI tools with their own data and under realistic workflow conditions. Only in this way can we maximize the productivity gains for the radiologists who will be the daily end users of AI applications,” says Oxipit CEO Gediminas Peksys. “We were very encouraged by the radiologist feedback from Teleradiología de Colombia and are delighted to work with such a forward-looking, innovation-driven partner.” 

This marks the first Oxipit AI software deployment in Colombia. More deployments in the LATAM region are soon to follow.

“Latin America presents a growing diagnostic imaging market with a high focus on innovations and efficiency,” adds Peksys.

Oxipit ChestEye AI imaging suite provides preliminary reports for 75 radiological findings. The platform also identifies healthy patient scans featuring no abnormalities with high certainty. Oxipit ChestEye recently received medical device certification in Australia and was granted a CE mark in 2019.

For more information, visit Oxipit